Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Availability”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Post-approval studies (Phase 4)Study completedNCT04882085
What this trial is testing

Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults

Who this might be right for
Urinary Tract InfectionAcute PyelonephritisHospital Acquired Pneumonia+3 more
Pfizer 60
Early research (Phase 1)Study completedNCT03706781
What this trial is testing

A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer

Who this might be right for
Healthy
Aziende Chimiche Riunite Angelini Francesco S.p.A 26
Large-scale testing (Phase 3)Ended earlyNCT00055198
What this trial is testing

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Who this might be right for
Gram-Positive Bacterial Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 75
Early research (Phase 1)Study completedNCT02119247
What this trial is testing

Study to Investigate the Pharmacokinetics of CHF 6001 DPI Administered Via Nexthaler® Device or the Capsule for Oral Inhalation Via Aerolizer® Device

Who this might be right for
COPD
Chiesi Farmaceutici S.p.A. 44
Early research (Phase 1)Study completedNCT02743013
What this trial is testing

Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers

Who this might be right for
COPD
Chiesi Farmaceutici S.p.A. 50
Not applicableStudy completedNCT06082726
What this trial is testing

The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers

Who this might be right for
Systemic AvailabilityIntestinal AbsorptionMetabolism+1 more
KU Leuven 13
Post-approval studies (Phase 4)Study completedNCT01943409
What this trial is testing

Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils

Who this might be right for
ObstructionCancerIleus+2 more
Johane Allard 303
Not applicableStudy completedNCT02177279
What this trial is testing

Bioactive Phytochemicals From Wheat Bran

Who this might be right for
Bio-availability of Wheat Bran Phytochemicals in the Human GutBio-availability of Wheat Bran Phytochemicals for the Systemic Circulation
University of Aberdeen 8
Not applicableLooking for participantsNCT07173868
What this trial is testing

FDG PET-CT in Advanced Breast Cancer

Who this might be right for
Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment AvailableIf There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Samsung Medical Center 100
Testing effectiveness (Phase 2)UnknownNCT00750971
What this trial is testing

Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)

Who this might be right for
Systemic Lupus Erythematosus
Charite University, Berlin, Germany 30
Not applicableNo Longer AvailableNCT05941637
What this trial is testing

An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)

Who this might be right for
Clear Cell Kidney CancerKidney CancerKidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
Lynkcell Europe
Not applicableStudy completedNCT01880034
What this trial is testing

Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments

Who this might be right for
Local Anesthetic Systemic Toxicity
University of Wisconsin, Madison 18
Large-scale testing (Phase 3)Ended earlyNCT04876430
What this trial is testing

Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionBloodstream Infection
Hospital de Clinicas de Porto Alegre 13
Not applicableLooking for participantsNCT05505617
What this trial is testing

Nitric Oxide Lung Diffusing Capacity in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Holger Dressel 23
Large-scale testing (Phase 3)Study completedNCT02168946
What this trial is testing

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Who this might be right for
Urinary Tract Infection ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+3 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 77
Testing effectiveness (Phase 2)WithdrawnNCT00230035
What this trial is testing

Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT01490008
What this trial is testing

Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers

Who this might be right for
Anogenital Warts
MediGene 30
Large-scale testing (Phase 3)Study completedNCT02714595
What this trial is testing

Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens

Who this might be right for
Healthcare-associated Pneumonia (HCAP)Bloodstream Infections (BSI)Hospital Acquired Pneumonia (HAP)+3 more
Shionogi 152
Testing effectiveness (Phase 2)Looking for participantsNCT07124078
What this trial is testing

Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

Who this might be right for
Chronic Graft-versus-host-disease
Incyte Corporation 60
Not applicableStudy completedNCT04695431
What this trial is testing

Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

Who this might be right for
Advanced Systemic MastocytosisAggressive Systemic MastocytosisSystemic Mastocytosis With an Associated Hematological Neoplasm+1 more
Blueprint Medicines Corporation 317
Load More Results